Current evidence on the circadian-time-dependent effects of hypertension medications and their combinations in relation to findings of MAPEC and Hygia Chronotherapy Trial

References

• Balan H. 2009. Bedtime versus at awakening administration of BP lowering drugs--is it the way to success? Rom J Intern Med. 47:355–361. doi:10.1007/s11906-018-0897-4.
   PubMedGoogle Scholar
• Bowles NP, Thosar SS, Herzig MX, Shea SA. 2018. Chronotherapy for hypertension. Curr Hypertens Rep. 20:97. doi:10.1007/s11906-018-0897-4.
   PubMed Web of Science ®Google Scholar
• Calberg B, Brunström M. 2020. Is bedtime the best time of the day? Hypertens News. 59:17–19. doi:10.30824/2003-9.
   Google Scholar
• De Giorgi A, Menegatti AM, Fabbian F, Portaluppi F, Manfredini R. 2013. Circadian rhythms and medical diseases: does it matter when drugs are taken? Eur J Intern Med. 24:698–706. doi:10.1016/j.ejim.2013.03.019.
   PubMed Web of Science ®Google Scholar
• Fernández JR, Mojón A, Hermida RC. 2020. Chronotherapy of hypertension: advantages of 48h ambulatory blood pressure monitoring assessments in MAPEC and hygia chronotherapy trial. Chronobiol Int. In press
   Web of Science ®Google Scholar
• Fujiwara T, Hoshide S, Yano Y, Kanegae H, Kario K. 2017. Comparison of morning vs bedtime administration of the combination of valsartan/amlodipine on nocturnal brachial and central blood pressure in patients with hypertension. J Clin Hypertens. 19:1319–1326. doi:10.1111/jch.13128.
   Web of Science ®Google Scholar
• Gupta R, Malik AH, Popli T, Ranchal P, Yandrapalli S, Aronow WS. 2020. Impact of bedtime dosing of antihypertensives compared to morning therapy: A meta-analysis of randomised controlled trials. Eur J Prev Cardiol. 204748732090361. Epub ahead of print. doi:10.1177/2047487320903611.
   Web of Science ®Google Scholar
• Henegham C, O’Sullivan J, Mahtani KR. 2020. Should blood pressure medications be taken at bedtime? BMJ Evid Based Med. bmjebm-2019–111311. [Epub ahead of print]. doi:10.1136/bmjebm-2019-111311.
   Google Scholar
• Hermida RC. 2016. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: rationale and design of the hygia project. Chronobiol Int. 33(7):906–936. doi:10.1080/07420528.2016.1181078.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Mojón A, Smolensky MH, Fabbian F, Portaluppi F. 2013a. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol Int. 30:280–314. doi:10.3109/07420528.2012.709448.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Portaluppi F, Fabbian F, Smolensky MH. 2011a. Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am J Hypertens. 24:383–391. doi:10.1038/ajh.2010.217.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. 2010a. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing. Chronobiol Int. 27:1287–1303. doi:10.3109/07420528.2010.489167.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2010b. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 27:1629–1651. doi:10.3109/07420528.2010.510230.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fontao MJ, Fernández JR. 2011b. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing. Chronobiol Int. 28:601–610. doi:10.3109/07420528.2011.589935.
   PubMed Web of Science ®Google Scholar
• Hermida RC. 2007. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study. Chronobiol Int. 24:749–775. doi:10.1080/07420520701535837.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Smolensky MH, Fernández JR, Mojón A, Portaluppi F. 2016. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hypertens Res. 39:277–292. doi:10.1007/s00125-015-3748-8.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Crespo JJ, Domínguez-Sardiña M, Otero A, Moyá A, Ríos MT, Sineiro E, Castiñeira MC, Callejas PA, Pousa L, et al. 2019. Bedtime hypertension treatment improves cardiovascular risk reduction: the hygia chronotherapy trial. European Heart Journal. Epub ahead of print. doi:10.1093/eurheartj/ehz754
   Google Scholar
• Hermida RC, Crespo JJ, Otero A, Domínguez-Sardiña M, Moyá A, Ríos MT, Castiñeira MC, Callejas PA, Pousa L, Sineiro E, et al. 2018. Asleep blood pressure: Significant prognostic marker of vascular risk and therapeutic target for prevention. Eur Heart J. 39:4159–4171. doi:10.1093/eurheartj/ehy475.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Mojón A, Fernández JR, for the Hygia Project Investigators. 2020. Bedtime hypertension chronotherapy best reduces cardiovascular disease prevention as documented by MAPEC and hygia chronotherapy outcomes trials. Chronobiol Int. In press
   Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Ayala DE, Portaluppi F, Crespo JJ, Fabbian F, Haus E, Manfredini R, Mojón A, Moyá A, et al. 2013b. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM).. Chronobiol Int. 30:355–410. doi:10.3109/07420528.2013.750490.
   PubMed Web of Science ®Google Scholar
• Hoshino A, Nakamura T, Matsubara H. 2010. The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy. Clin Exp Hypertens. 32:416–422. doi:10.3109/10641961003667948.
   PubMed Web of Science ®Google Scholar
• Huangfu W, Duan P, Xiang D, Gao R. 2015. Administration time-dependent effects of combination therapy on ambulatory blood pressure in hypertensive subjects.. Int J Clin Exp Med. 8:19156–19161.
   PubMed Web of Science ®Google Scholar
• Hughes S. 2019. Bedtime dosing of hypertension meds reduces CV events. Medscape Posted Oct. 31:2019.
   Google Scholar
• Kario K, Hoshide S, Uchiyama K, Yoshida T, Okazaki O, Noshiro T, Aoki H, Mizuno H, Matsumoto Y. 2016. Dose timing of an angiotensin II receptor blocker/calcium channel blocker combination in hypertensive patients with paroxysmal atrial fibrillation. The Journal of Clinical Hypertension. 18:1036–1044. doi:10.1111/jch.12814.
   Web of Science ®Google Scholar
• Kim SYH, Miller FG. 2015. Ethical complexities in standard of care randomized trials: A case study of morning versus nighttime dosing of blood pressure drugs. Clin Trials. 12:557–563. doi:10.1177/1740774515607213.
   PubMed Web of Science ®Google Scholar
• Kittel M. 2019. NICE guidance on hypertension in adults: take blood pressure tablets at night, measure blood pressure at home. BMJ. 367:I6570. doi:10.1136/bmj.I6570.
   Google Scholar
• Lemmer B. 2000. Cardiovascular chronobiology and chronopharmacology. Importance of timing of dosing. In: White WB, Eds. Blood pressure monitoring in cardiovascular medicine and therapeutics. Totowa (NJ): Humana Press, pp. 255–271.
   Google Scholar
• Lemmer B. 2007. Chronobiology and chronopharmacology of hypertension. Importance of timing of dosing. In: White WB, Eds. Blood pressure monitoring in cardiovascular medicine and therapeutics. 2nd edic. Totowa (NJ): Humana Press, p.p 413–435.
   Google Scholar
• Lemmer B, Middeke M. 2020. A commentary of the Spanish hypertension studies MAPEC and hygia. Chronobiol Int. In press
   PubMed Web of Science ®Google Scholar
• Meng Y, Zhang Z, Liang X, Wu C, Qi G. 2010. Effects of combination therapy with amlodipine and fosinopril administered at different times on blood pressure and circadian blood pressure pattern in patients with essential hypertension. Acta Cardiologica. 65:309–314. doi:10.2143/AC.65.3.2050347.
   PubMed Web of Science ®Google Scholar
• Middeke M, Klüglich M, Holzgreve H. 1991. Chronopharmacology of captopril plus hydrochlorothiazide in hypertension: morning versus evening dosing. Chronobiol Int. 8(6):506–510.
   PubMed Web of Science ®Google Scholar
• Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC, Nakhla M, Cloutier L, Gelfer M, et al. 2018. Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children. Can J Cardiol. 34:506–525. doi:10.1016/j.cjca.2018.02.022.
   PubMed Web of Science ®Google Scholar
• Nold N, Strobel S, Lemmer L. 1998. Morning versus evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients.. Blood pressure Monitoring. 3:17–25.
   PubMedGoogle Scholar
• Ohishi M, Kawai T, Hayashi N, Kitano S, Katsuya T, Nagano M, Hirotani A, Yamamoto K, Kamide K, Rakugi H. 2013. Effect of tablets with a combination of telmisartan and amlodipine on patients with hypertension: the cotalo study. Hypertens Res. 36(7):620–626. doi:10.1038/hr.2013.10.
   PubMed Web of Science ®Google Scholar
• Okeahialam BN, Ohihoin EN, Ajuluchukwu JN. 2012. Diuretic drugs benefit patients with hypertension more with night-time dosing. Therapeutic Advances in Drug Safety. 3:273–278. doi: 10.1177/2042098612459537.
   PubMedGoogle Scholar
• Peng G-C, Wang Y-F, Xiao Y, Chen J-F, Yang Y, Ye Y-L, Sai S-Q, Huang J-X. 2013. [Blood pressure lowering efficacy of telmisartan and amlodipine taking on the morning or at bedtime: ABPM results].. Zhonghua Xin Xue Guan Bing Za Zhi. 41:484–487.
   PubMedGoogle Scholar
• Portaluppi F, Smolensky MH. 2010. Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Chronobiol Int. 27:1652–1667. doi:10.3109/07420528.2010.510788.
   PubMed Web of Science ®Google Scholar
• Schillaci G, Battista F, Settimi L, Schillaci L, Pucci G. 2015. Antihypertensive drug treatment and circadian blood pressure rhythm: a review of the role of chronotherapy in hypertension. Curr Pharm Des. 21:756–772. doi:10.2174/1381612820666141024130013.
   PubMed Web of Science ®Google Scholar
• Schulz KF, Altman DG, Moher D; for the CONSORT group. 2010. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 340:c332. doi:10.1136/bmj.c332.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Ayala DE, Portaluppi F. 2015. Bedtime hypertension chronotherapy: Concepts and patient outcomes. Curr Pharm Des. 21:773–790. doi:10.2174/1381612820666141024150542.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. 2010. Administration-time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension.. Blood pressure Monitoring. 15:173–180. doi:10.1097/MBP.0b013e32833c7308.
   PubMed Web of Science ®Google Scholar
• Stranges PM, Drew AM, Rafferty P, Shuster JE, Brooks AD. 2015. Treatment of hypertension with chronotherapy: is it time of drug administration? Ann Pharmacother. 49(3):323–334. doi:10.1177/1060028014563535.
   PubMed Web of Science ®Google Scholar
• Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, Horio T, Hoshide S, Ikeda S, Ishimitsu T, et al. 2019. The japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 42:1235–1481. doi:10.1038/s41440-019-0284-9.
   PubMed Web of Science ®Google Scholar
• Vernon G. 2017. The chronotherapy of hypertension: or the benefit of taking blood pressure tablets at bedtime. Br J Gen Pract. 67(657):171. doi:10.3399/bjgp17X690269.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb CD, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. 2018. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the american college of cardiology/american heart association task force on clinical practice guidelines.. J Am Coll Cardiol. 71(19):e127–e248. doi:10.1016/j.jacc.2017.11.006.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 39:3021–3104. doi:10.1093/eaurheartj/ehy339.
   PubMed Web of Science ®Google Scholar
• Wingo MT, Bornstein SL, Szostek JH, Mauck KF, Post JA, Wieland ML. 2020. Update in outpatient general internal medicine: Practice-changing evidence published in 2019. Am J Med. 133. in press. doi:10.1016/j.amjmed.2020.03.033.
   PubMedGoogle Scholar
• Witte K, Weisser K, Neubeck M, Mutschler E, Lehmann K, Hopf R, Lemmer B. 1993. Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther. 54:177–186.
   PubMed Web of Science ®Google Scholar
• Zeng J, Jia M, Ran H, Tang H, Zhang Y, Zhang J, Wang X, Wang H, Yang C, Zeng C. 2011. Fixed-combination of amlodipine and diuretic chronotherapy in the treatment of essential hypertension: improved blood pressure control with bedtime dosing—a multicenter, open-label randomized study. Hypertens Res. 34:767–772. doi:10.1038/hr.2011.36.
   PubMed Web of Science ®Google Scholar
• Zhao P, Xu P, Wan C, Wang Z. 2011. Evening versus morning dosing regimen drug therapy for hypertension. Cochrane Database Syst Rev. 10:CD004184. doi:10.1002/14651858.CD004184.pub2.
   Google Scholar